|
TRVI Trevi Therapeutics Inc 1563880 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-17,797,000.00 |
| Balance Sheet |
|
Current Assets
|
$325,705,000.00 |
|
Assets
|
$330,518,000.00 |
|
Current Liabilities
|
$8,736,000.00 |
|
Liabilities
|
$9,012,000.00 |
|
Equity
|
$321,506,000.00 |
|
Shares Out
|
142420883.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-34,118,000.00 |
|
Investing Cash Flow
|
$-95,073,000.00 |
| Market Analysis |
Market Cap
|
$2,599,181,114.75 |
|
Price
|
$14.95 |
|
BVPS
|
2.26 |
|
PB
|
8.08 |
|
EPS
|
-0.11 |
|
FCF
|
$-34,344,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:20 |
|
| Apr |
May |
Jun |
| 2026-03-17 |
-0.06 |
|
|
2026-05-05 |
-0.09 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.09 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRVI documents filed with the SEC.
TRVI Filings
Clear
